News & Media

SK life science

Welcome to the news and information center for SK Life Science, Inc. (SKLSI), a CNS-focused pharmaceutical company

Here you will find the latest announcements and contact information for SK life science.

For media inquiries, please contact .

Download fact sheet

General business

Strategic alliance and partnership opportunities

Media inquiries and PR

Grants and sponsorship requests

SK life science at a glance

  • Headquarters location


  • Year Established


  • Parent Company

    SK life science is a subsidiary of SK Biopharmaceuticals, Co., Ltd., and both are part of the SK Group

  • Number of employees


  • Disease Category Focus


  • Pipeline

    8 compounds under clinical development

Press releases

SK life science presents new data on its lead investigational compound, cenobamate, at the American Epilepsy Society 2018 Annual Meeting

Full release

SK life science honors Epilepsy Awareness Month with support for patients, advocates, caregivers, and healthcare providers

Full release

SK life science awards educational grant to J. Kiffin Penry Epilepsy Education Programs in support of neurology residents and epilepsy fellows

Full release

SK life science presents data on the investigational antiepileptic drug, cenobamate, at the American Academy of Neurology Annual Meeting 2018

Full release

SK life science to present data on cenobamate, an investigational antiepileptic compound, at ASCPT 2018 Annual Meeting

Full release

SK life science launches new corporate presence, expanded commercial operations in the United States.

Full release